Stella Paffenholz, PhD

Senior Associate, Atlas Venture
Stella Paffenholz, MS
Dissertation
Flexible Preclinical Models of High-Grade Serous Ovarian Carcinoma to Elucidate Mechanisms of Treatment Sensitivity and Resistance (2022)
Mentor
Scott W. Lowe, PhD
Start Year
2016
End Year
2023
Education
PhD, Gerstner Sloan Kettering Graduate School, New York, NY; Cancer Biology

Graduate Student in Lowe Lab from 2016-2022.

Publications

Paffenholz SV, Salvagno C, Ho YJ, Limjoco M, Baslan T, Tian S, Kulick A, de Stanchina E, Wilkinson JE, Barriga FM, Zamarin D, Cubillos-Ruiz JR, Leibold J, Lowe SW. (2022) Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer. Proc Natl Acad Sci USA.

Sánchez-Rivera FJ, Diaz BJ, Kastenhuber ER, Schmidt H, Katti A, Kennedy M, Tem V, Ho YJ, Leibold J, Paffenholz SV, Barriga FM, Chu K, Goswami S, Wuest AN, Simon JM, Tsanov KM, Chakravarty D, Zhang H, Leslie CS, Lowe SW, Dow LE. (2022) Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants. Nat Biotechnol. Online ahead of print.

View a full listing of Stella Paffenholz’s journal articles.